A Clinical Trial to Test an Ocular Implant that Releases Ranibizumab Compared with Eye Injections of Ranibizumab in Patients with Wet Age-Related Macular Degeneration (Archway)
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
-
Eye Disorder -
Age-Related Macular Degeneration -
Neovascular Age-related Macular Degeneration
For the latest version of this information please go to www.forpatients.roche.com